Hemoglobin A1c Testing Devices Market to Grow at 8.8% CAGR by 2030 | Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd.

"The Global Hemoglobin A1c Testing Devices Market reached US$ 1.5 billion in 2024 and is expected to reach US$ 3.2 billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033." As per DataM intelligence research report

Hemoglobin A1c Testing Devices Market growth opportunities(2025-2031):

The global shift toward preventive healthcare is significantly driving the demand for Hemoglobin A1c (HbA1c) testing devices. These devices are critical for diabetes diagnosis and long-term monitoring, and their usage is expanding across hospitals, clinics, and home-care settings. Rising diabetes prevalence, increasing awareness of early detection, and growing adoption of point-of-care (POC) testing solutions are major growth enablers. Additionally, government screening programs and integration with electronic health records (EHR) are promoting routine HbA1c testing. Manufacturers are focusing on compact, user-friendly, and rapid-result systems to cater to both developed and emerging healthcare markets.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/hemoglobin-a1c-testing-devices-market?sp

Hemoglobin A1c Testing Devices Market: Recent Industry Developments

✅ In July 2025, Abbott launched its Afinion 4 HbA1c Analyzer across key U.S. and European markets.The new device delivers lab-quality results in under 3 minutes at the point of care.It supports multi-analyte testing and is aimed at expanding diabetes monitoring in clinics.

✅ In June 2025, Siemens Healthineers unveiled the upgraded DCA Vantage Analyzer for HbA1c testing.Now with cloud connectivity and touchscreen interface, it streamlines workflow in primary care.The device is CLIA-waived and suited for decentralized diabetes management.

✅ In May 2025, EKF Diagnostics received CE mark for its Quo-Test A1c device with built-in patient ID scanner.It offers quick, cartridge-based testing ideal for small clinics and mobile units.The company has begun expanding its European distribution network aggressively.

✅ In April 2025, PTS Diagnostics launched a pilot program for its A1CNow+ Pro in community pharmacies.It enables walk-in patients to get instant HbA1c readings using fingerstick samples.The move supports early diagnosis and proactive glycemic control in underserved areas.

✅ In March 2025, Bio-Rad Laboratories invested $30 million to enhance its Variant II Turbo analyzer line.This high-throughput lab device supports both HbA1c and hemoglobinopathies testing.The expansion is targeted at large hospitals and reference labs across Europe and the U.S.

Hemoglobin A1c Testing Devices Market: Drivers

The Hemoglobin A1c testing devices market is driven by the rising global prevalence of diabetes, making long-term glycemic monitoring essential for effective disease management. There is increasing emphasis on preventive care and early diagnosis, prompting routine HbA1c screening in both clinical and outpatient settings. The shift toward point-of-care testing has led to greater use of compact, portable devices that deliver faster results and improve treatment decisions. Technological innovations, such as biosensors and lab-on-chip platforms, are enhancing device accuracy and ease of use. Expanding insurance coverage and government support for diabetes testing are helping to reduce patient costs and boost overall adoption.

The market is further fueled by the rise of at-home and connected testing solutions, enabling remote monitoring and integration with telehealth platforms. Growth across emerging economies is accelerating due to improved healthcare infrastructure, increasing diabetes awareness, and expanded screening programs. Strategic collaborations between diagnostics firms and tech companies are leading to more advanced and user-friendly device offerings. Hospitals and diagnostic labs are upgrading equipment to more efficient systems, supported by rising investment in healthcare modernization. Increased public awareness around the benefits of long-term blood sugar monitoring is also driving regular HbA1c testing in both self-care and clinical environments.

Hemoglobin A1c Testing Devices Market: Technological Advancements

✦ Point-of-Care (POC) HbA1c analyzers provide rapid and accurate results within minutes, enhancing real-time treatment decisions and patient engagement.
✦ Integration with electronic medical records (EMR) streamlines data tracking and patient history, improving chronic disease management.
✦ Portable and handheld testing devices support at-home monitoring and are particularly beneficial for rural or resource-limited settings.
✦ Non-invasive HbA1c testing research is advancing, aiming to eliminate the need for finger pricks and improve patient compliance.
✦ Automated high-throughput laboratory systems increase efficiency and reliability in large-scale testing environments.

Strategic Players Driving the Hemoglobin A1c Testing Devices Market Forward:

Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., EKF Diagnostics Holdings plc., Trinity Biotech Plc., A. Menarini Diagnostics s.r.l, ARKRAY, Inc., Tosoh India Pvt. Ltd., PTS Diagnostics, Siemens Healthcare Private Limited and among others

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/hemoglobin-a1c-testing-devices-market?sp

Research Methodology:

The global Hemoglobin A1c Testing Devices Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Hemoglobin A1c Testing Devices Market:

➥By Type: Laboratory-based Testing Devices, Point-of-Care (POC) Testing Devices
➥By Technology: Immunoassays, Chromatography, Enzymatic Assays, Others
➥By End-User: Hospitals, Diagnostic Laboratories, Homecare Settings, Academic & Research Institutes, Others

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=hemoglobin-a1c-testing-devices-market?sp

Regional Analysis for Hemoglobin A1c Testing Devices Market:

North America dominates the HbA1c testing device market due to a high diabetic population, favorable reimbursement, and advanced healthcare infrastructure. Europe follows closely, with strong demand from countries like Germany, France, and the UK driven by early detection campaigns and widespread adoption of POC devices. The Asia-Pacific region is poised for rapid growth due to increasing diabetes awareness, expanding diagnostic infrastructure, and supportive government screening initiatives.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.